Related Experiment Video
Updated: May 14, 2026

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
MicroRNA dysregulation in multiple sclerosis
Omar de Faria1, Craig S Moore, Timothy E Kennedy
1Department of Neurology and Neurosurgery, The Montreal Neurological Institute and Hospital, McGill University Health Centre, McGill University Montreal, QC, Canada ; Program in NeuroEngineering, McGill University Montreal, QC, Canada.
Abstract:
Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) demyelination and axonal degeneration. Although the cause of MS is still unknown, it is widely accepted that novel drug targets need to focus on both decreasing inflammation and promoting CNS repair. In MS and experimental autoimmune encephalomyelitis, non-coding small microRNAs (miRNAs) are dysregulated in the immune system and CNS. Since individual miRNAs are able to down-regulate multiple targeted mRNA transcripts, even minor changes in miRNA expression may lead to significant alterations in gene expression. Herein, we review miRNA signatures reported in CNS tissue and immune cells of MS patients and consider how altered miRNA expression may influence MS pathology.
Insights
MicroRNAs (miRNAs) are dysregulated in multiple sclerosis (MS), impacting gene expression in the central nervous system (CNS) and immune cells. Understanding these miRNA signatures is crucial for developing new MS therapeutic targets.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Genetics
Background:
- Multiple sclerosis (MS) is a chronic CNS inflammatory disease with demyelination and axonal loss.
- Current MS treatments aim to reduce inflammation and promote repair, but novel drug targets are needed.
- Non-coding small microRNAs (miRNAs) are implicated in MS pathogenesis due to their regulatory roles.
Purpose of the Study:
- To review reported miRNA signatures in CNS tissue and immune cells of MS patients.
- To explore the influence of altered miRNA expression on MS pathology.
- To identify potential miRNA-based therapeutic strategies for MS.
Main Methods:
- Literature review of studies reporting miRNA expression in MS.
- Analysis of miRNA dysregulation in central nervous system (CNS) tissue and peripheral immune cells.
- Correlation of miRNA alterations with MS disease mechanisms.
Main Results:
- MiRNA expression profiles are altered in both CNS and immune cells in MS patients.
- Dysregulated miRNAs can affect multiple gene targets, influencing inflammatory and repair pathways.
- Specific miRNA signatures are associated with MS pathology.
Conclusions:
- Altered miRNA expression is a significant feature of MS.
- MiRNAs represent promising targets for novel MS therapies focused on immune modulation and CNS repair.
- Further research into miRNA function in MS is warranted.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Multiple Sclerosis l: Introduction

